PMID- 27810898 OWN - NLM STAT- MEDLINE DCOM- 20170601 LR - 20231213 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 291 IP - 52 DP - 2016 Dec 23 TI - MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) Interaction Disruptor Sensitizes Insulin Signaling in Skeletal Muscle. PG - 26627-26635 LID - 10.1074/jbc.M116.754424 [doi] AB - Mitsugumin 53 (MG53) is an E3 ligase that interacts with and ubiquitinates insulin receptor substrate-1 (IRS-1) in skeletal muscle; thus, an MG53-IRS-1 interaction disruptor (MID), which potentially sensitizes insulin signaling with an elevated level of IRS-1 in skeletal muscle, is an excellent candidate for treating insulin resistance. To screen for an MID, we developed a bimolecular luminescence complementation system using an N-terminal luciferase fragment fused with IRS-1 and a C-terminal luciferase fragment fused with an MG53 C14A mutant that binds to IRS-1 but does not have E3 ligase activity. An MID, which was discovered using the bimolecular luminescence complementation system, disrupted the molecular association of MG53 with IRS-1, thus abolishing MG53-mediated IRS-1 ubiquitination and degradation. Thus, the MID sensitized insulin signaling and increased insulin-elicited glucose uptake with an elevated level of IRS-1 in C2C12 myotubes. These data indicate that this MID holds promise as a drug candidate for treating insulin resistance. CI - (c) 2016 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Lee, Hyun AU - Lee H AD - From the Division of Life Sciences and. FAU - Park, Jung-Jin AU - Park JJ AD - From the Division of Life Sciences and. FAU - Nguyen, Nga AU - Nguyen N AD - From the Division of Life Sciences and. FAU - Park, Jun Sub AU - Park JS AD - From the Division of Life Sciences and. FAU - Hong, Jin AU - Hong J AD - From the Division of Life Sciences and. FAU - Kim, Seung-Hyeob AU - Kim SH AD - From the Division of Life Sciences and. FAU - Song, Woon Young AU - Song WY AD - the Department of Chemistry, Korea University, Seoul, 02841, Korea. FAU - Kim, Hak Joong AU - Kim HJ AD - the Department of Chemistry, Korea University, Seoul, 02841, Korea. FAU - Choi, Kwangman AU - Choi K AD - the Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Korea, and. FAU - Cho, Sungchan AU - Cho S AD - the Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Korea, and. FAU - Lee, Jae-Seon AU - Lee JS AD - the Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, 22212, Korea. FAU - Kim, Bong-Woo AU - Kim BW AUID- ORCID: 0000-0001-8767-9519 AD - From the Division of Life Sciences and kbw96@korea.ac.kr. FAU - Ko, Young-Gyu AU - Ko YG AD - From the Division of Life Sciences and ygko@korea.ac.kr. LA - eng PT - Journal Article DEP - 20161103 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Carrier Proteins) RN - 0 (IRS1 protein, human) RN - 0 (Insulin) RN - 0 (Insulin Receptor Substrate Proteins) RN - 0 (Microtubule Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Small Molecule Libraries) RN - 0 (TRIM72 protein, human) RN - 0 (Transcription Factors) RN - 0 (Tripartite Motif Proteins) RN - EC 2.3.2.27 (MID1 protein, human) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) SB - IM MH - Carrier Proteins/*metabolism MH - Cells, Cultured MH - Humans MH - Insulin/*metabolism MH - Insulin Receptor Substrate Proteins/*metabolism MH - Insulin Resistance MH - Microtubule Proteins/*metabolism MH - Muscle Fibers, Skeletal/cytology/drug effects/metabolism MH - Muscle, Skeletal/drug effects/*metabolism MH - Nuclear Proteins/*metabolism MH - Phosphorylation/drug effects MH - Protein Interaction Maps/*drug effects MH - Proteolysis MH - Signal Transduction/drug effects MH - Small Molecule Libraries/*pharmacology MH - Transcription Factors/*metabolism MH - Tripartite Motif Proteins MH - Ubiquitin-Protein Ligases/metabolism MH - Ubiquitination PMC - PMC5207173 OTO - NOTNLM OT - diabetes OT - drug discovery OT - insulin receptor substrate 1 (IRS-1) OT - insulin resistance OT - skeletal muscle EDAT- 2016/11/05 06:00 MHDA- 2017/06/02 06:00 PMCR- 2017/12/23 CRDT- 2016/11/05 06:00 PHST- 2016/08/18 00:00 [received] PHST- 2016/11/01 00:00 [revised] PHST- 2016/11/05 06:00 [pubmed] PHST- 2017/06/02 06:00 [medline] PHST- 2016/11/05 06:00 [entrez] PHST- 2017/12/23 00:00 [pmc-release] AID - S0021-9258(20)34417-3 [pii] AID - M116.754424 [pii] AID - 10.1074/jbc.M116.754424 [doi] PST - ppublish SO - J Biol Chem. 2016 Dec 23;291(52):26627-26635. doi: 10.1074/jbc.M116.754424. Epub 2016 Nov 3.